Neurocrine Biosciences
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Neurocrine Biosciences's balance sheet done over the years? Its assets were worth $3,251,400,000 last year, which is more than in the previous period. 31% of Neurocrine Biosciences’s total assets is currently financed by debt. Its liabilities reached the amount of $1,019,400,000, which means an increase by 54% compared compared to last year.
Debt to Assets
| 2014 | 243033000 | 34.33M | 14.13% |
|---|---|---|---|
| 2015 | 474785000 | 50.33M | 10.6% |
| 2016 | 365086000 | 50.20M | 13.75% |
| 2017 | 817591000 | 445.45M | 54.48% |
| 2018 | 993151000 | 512.38M | 51.59% |
| 2019 | 1306000000 | 669.1M | 51.23% |
| 2020 | 1734700000 | 608.5M | 35.08% |
| 2021 | 2072500000 | 698.5M | 33.7% |
| 2022 | 2368700000 | 660.9M | 27.9% |
| 2023 | 3251400000 | 1.01B | 31.35% |
NBIX Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 251.1M | 262.9M | 340.8M | 801M | 112.27M | 141.71M | 254.71M | 83.26M | 74.19M | 31.01M |
Short term investments | 780.5M | 726.4M | 370.5M | 613.9M | 558.24M | 509.19M | 261.21M | 224.08M | 304.99M | 162.79M |
Net receivables | 439.3M | 350M | 185.5M | 157.1M | 126.57M | 56.24M | 31.12M | 0 | 0 | 0 |
Inventory | 38.3M | 35.1M | 30.5M | 28M | 17.28M | 10.86M | -31.12M | 0 | 0 | 0 |
Other current assets | 97.8M | 464.2M | 261.5M | 215.2M | 160.5M | 86.86M | 7.86M | 3.09M | 4.88M | 4.39M |
Total current assets | 1.60B | 1.45B | 972.8M | 1.01B | 831M | 737.77M | 554.91M | 310.44M | 384.07M | 198.20M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 347.3M | 145.6M | 155.8M | 127.4M | 116.2M | 33.86M | 10.81M | 6.27M | 3.43M | 2.50M |
Goodwill | 0 | 5.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 35.5M | 37.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 849.4M | 401.5M | 624.4M | 265.3M | 355.6M | 216.02M | 247.36M | 43.49M | 82.48M | 37.49M |
Other non-current assets | 49.6M | 25M | 4.4M | 6.4M | 3.2M | 5.47M | 4.5M | 4.88M | 4.79M | 4.83M |
Total non-current assets | 1.64B | 915.2M | 1.09B | 718.5M | 475M | 255.37M | 262.67M | 54.64M | 90.71M | 44.83M |
Total assets | 3.25B | 2.36B | 2.07B | 1.73B | 1.30B | 993.15M | 817.59M | 365.08M | 474.78M | 243.03M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | -16.5M | -10.3M | -46.21M | 10.23M | 10.23M | 10.23M | 10.23M | 0 |
Short term debt | 170.1M | 169.4M | 16.5M | 10.3M | 408.8M | 62.34M | 0 | 14.86M | 0 | 0 |
Total current liabilities | 654.8M | 537.7M | 245.8M | 186.5M | 565.3M | 88.23M | 54.42M | 30.41M | 25.71M | 15.66M |
| Non-current liabilities: | ||||||||||
Long term debt | 258.3M | 93.5M | 440.4M | 412.3M | 86.7M | 388.49M | 369.61M | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 106.3M | 29.7M | 12.3M | 9.7M | 17.1M | 35.65M | 21.40M | 9.56M | 24.61M | 18.67M |
Total non-current liabilities | 364.6M | 123.2M | 452.7M | 422M | 103.8M | 424.15M | 391.02M | 19.79M | 24.61M | 18.67M |
Total liabilities | 1.01B | 660.9M | 698.5M | 608.5M | 669.1M | 512.38M | 445.45M | 50.20M | 50.33M | 34.33M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |